JP2005512962A5 - - Google Patents

Download PDF

Info

Publication number
JP2005512962A5
JP2005512962A5 JP2003528864A JP2003528864A JP2005512962A5 JP 2005512962 A5 JP2005512962 A5 JP 2005512962A5 JP 2003528864 A JP2003528864 A JP 2003528864A JP 2003528864 A JP2003528864 A JP 2003528864A JP 2005512962 A5 JP2005512962 A5 JP 2005512962A5
Authority
JP
Japan
Prior art keywords
antibody
designed
sequence
region
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003528864A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005512962A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/030086 external-priority patent/WO2003025019A1/en
Publication of JP2005512962A publication Critical patent/JP2005512962A/ja
Publication of JP2005512962A5 publication Critical patent/JP2005512962A5/ja
Withdrawn legal-status Critical Current

Links

JP2003528864A 2001-09-20 2002-09-20 抗pdgf抗体および設計抗体の産生方法 Withdrawn JP2005512962A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32354401P 2001-09-20 2001-09-20
US32353701P 2001-09-20 2001-09-20
US37999402P 2002-05-13 2002-05-13
PCT/US2002/030086 WO2003025019A1 (en) 2001-09-20 2002-09-20 Anti-pdgf antibodies and methods for producing engineered antibodies

Publications (2)

Publication Number Publication Date
JP2005512962A JP2005512962A (ja) 2005-05-12
JP2005512962A5 true JP2005512962A5 (cg-RX-API-DMAC7.html) 2005-12-22

Family

ID=27406282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003528864A Withdrawn JP2005512962A (ja) 2001-09-20 2002-09-20 抗pdgf抗体および設計抗体の産生方法

Country Status (4)

Country Link
EP (1) EP1436329A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005512962A (cg-RX-API-DMAC7.html)
CA (1) CA2460587A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003025019A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393648B2 (en) 2001-12-03 2008-07-01 Alexion Pharmaceuticals, Inc. Hybrid antibodies
JP4723810B2 (ja) 2001-12-03 2011-07-13 アレクシオン ファーマシューティカルズ, インコーポレイテッド ハイブリッド抗体
AU2003213022A1 (en) * 2002-02-11 2003-09-22 Alexion Pharmaceuticals, Inc. Immunotherapeutics for biodefense
NZ542988A (en) * 2003-04-23 2008-07-31 Medarex Inc Humanised antibodies directed against the IFNAR-1 receptor in which murine CDR sequences have been grafted directly into unmodified human framework sequences, resulting in high affinity, functional antibodies
NZ592039A (en) 2003-08-27 2013-03-28 Ophthotech Corp Combination therapy for the treatment of ocular neovascular disorders
US7276585B2 (en) * 2004-03-24 2007-10-02 Xencor, Inc. Immunoglobulin variants outside the Fc region
US7592429B2 (en) * 2005-05-03 2009-09-22 Ucb Sa Sclerostin-binding antibody
WO2009129538A2 (en) * 2008-04-18 2009-10-22 Xencor, Inc. Human equivalent monoclonal antibodies engineered from nonhuman variable regions
US20120189641A1 (en) 2009-02-25 2012-07-26 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
JP2012519282A (ja) 2009-02-27 2012-08-23 オーエスアイ・ファーマシューティカルズ,エルエルシー 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法
WO2010099138A2 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
US8642834B2 (en) 2009-02-27 2014-02-04 OSI Pharmaceuticals, LLC Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
JP2014519813A (ja) 2011-04-25 2014-08-21 オーエスアイ・ファーマシューティカルズ,エルエルシー 癌薬剤発見、診断、および治療におけるemt遺伝子シグネチャーの使用
JO3787B1 (ar) 2012-03-15 2021-01-31 Janssen Biotech Inc أجسام مضادة بشرية ضد cd27 و طرق و استخداماتها
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
SG11201408196RA (en) * 2012-06-28 2015-03-30 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
WO2014052518A1 (en) 2012-09-27 2014-04-03 Allergan, Inc. Biodegradable drug delivery systems for the sustained release of proteins
CN105188759A (zh) 2013-03-14 2015-12-23 阿勒根公司 持续释放递送的组合物以及在制造过程中稳定蛋白质的方法
SI4374873T1 (sl) 2013-07-12 2026-01-30 Astellas Us Llc Sredstvo za uporabo pri zdravljenju ali preprečevanju oftalmoloških stanj
JP2019006732A (ja) * 2017-06-27 2019-01-17 学校法人東京理科大学 Mycタンパク質阻害剤、Mycタンパク質阻害方法、抗神経芽腫剤及びMycタンパク質の過剰発現を伴う疾患の治療方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5817310A (en) * 1991-12-02 1998-10-06 Cor Therapeutics, Inc. Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
US5976534A (en) * 1993-02-25 1999-11-02 Zymogenetics, Inc. Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
AU1454199A (en) * 1997-11-07 1999-05-31 Massachusetts Institute Of Technology Pdgf-mediated microvascular communication and methods of use thereof
WO1999029888A1 (en) * 1997-12-05 1999-06-17 The Scripps Research Institute Humanization of murine antibody

Similar Documents

Publication Publication Date Title
JP2025000787A5 (cg-RX-API-DMAC7.html)
AU2013327116B2 (en) Combination of anti-KIR antibodies and anti-PD-1 antibodies to treat cancer
JP5889923B2 (ja) c−METの二量体化を阻害する新規な抗体およびその使用
JP2021524268A5 (cg-RX-API-DMAC7.html)
US20140212423A1 (en) Blood-brain barrier penetrating dual specific binding proteins
JP2018070648A5 (cg-RX-API-DMAC7.html)
IL261666B2 (en) Binding proteins and methods of use thereof
JP2019526622A5 (cg-RX-API-DMAC7.html)
JP2019535254A5 (ja) 抗pd−l1抗体および変異型
JP2018502840A5 (cg-RX-API-DMAC7.html)
JP2017512765A5 (cg-RX-API-DMAC7.html)
CA2587158A1 (en) Immunoglobulin variable region cassette exchange
JP2023549537A5 (cg-RX-API-DMAC7.html)
RU2013136172A (ru) Белки, связывающие антиген фактор роста, подобный гепаринсвязывающему эпидермальному фактору роста
JP2012532851A5 (cg-RX-API-DMAC7.html)
JP2013510868A5 (cg-RX-API-DMAC7.html)
JP2010536384A5 (cg-RX-API-DMAC7.html)
JP2017500057A5 (cg-RX-API-DMAC7.html)
JP2018522888A5 (cg-RX-API-DMAC7.html)
JP2021522347A5 (cg-RX-API-DMAC7.html)
JP2020533016A5 (cg-RX-API-DMAC7.html)
NZ598670A (en) Antibodies against glucagon receptor and their use
JP2024511137A5 (cg-RX-API-DMAC7.html)
JP2022513350A5 (cg-RX-API-DMAC7.html)
JP2011521966A5 (cg-RX-API-DMAC7.html)